Abiopharma

Alnylam präsentiert Fortschritte bei der Transformation der Behandlung von Herz-Kreislauf-Erkrankungen mit RNAi-Therapeutika auf dem Kongress der European Society of Cardiology 2025

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000094 Size: 6 KB

Summit Plc - Current report filing

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000092 Size: 6 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000090 Size: 6 KB

New Form 4 - Cronos Group Inc. Filed: 2025-08-11 AccNo: 0001656472-25-000081 Size: 5 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000088 Size: 6 KB

New Form 4 - Cronos Group Inc. Filed: 2025-08-11 AccNo: 0001656472-25-000080 Size: 5 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000086 Size: 6 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000084 Size: 6 KB

New Form 4 - Cronos Group Inc. Filed: 2025-08-11 AccNo: 0001656472-25-000079 Size: 5 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000082 Size: 7 KB

New Form 3 - Cronos Group Inc. Filed: 2025-08-11 AccNo: 0001656472-25-000078 Size: 6 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000080 Size: 6 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000078 Size: 6 KB